Tlr7 ligands for the treatment of hepatitis c

作者: Devron R. Averett

DOI:

关键词:

摘要: This invention relates to methods for treating or preventing hepatitis C virus infections in mammals using Toll-Like Receptor (TLR)7 ligands and prodrugs thereof. More particularly, this of orally administering a therapeutically effective amount one more TLR7 the treatment prevention viral infection. Oral administration these immunomodulating thereof mammal provides amounts reduced undesirable side effects.

参考文章(8)
J. RHODES, Discovery of immunopotentiatory drugs: current and future strategies. Clinical and Experimental Immunology. ,vol. 130, pp. 363- 369 ,(2002) , 10.1046/J.1365-2249.2002.02016.X
J. Lee, T.-H. Chuang, V. Redecke, L. She, P. M. Pitha, D. A. Carson, E. Raz, H. B. Cottam, Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 100, pp. 6646- 6651 ,(2003) , 10.1073/PNAS.0631696100
Allen B. Reitz, Michael G. Goodman, Barbara L. Pope, Dennis C. Argentieri, Stanley C. Bell, Levelle E. Burr, Erika Chourmouzis, Jon Come, Jacquelyn H. Goodman, Small-Molecule Immunostimulants. Synthesis and Activity of 7,8-Disubstituted Guanosines and Structurally Related Compounds Journal of Medicinal Chemistry. ,vol. 37, pp. 3561- 3578 ,(1994) , 10.1021/JM00047A014
Erik J. Rueden, Joseph R. Lennox, Alan X. Xiang, David Louis Clark, Stephen E. Webber, Devron R. Averett, 3-beta-D-ribofuranosylthiazolo[4-5-d]pyridimine nucleosides and uses thereof ,(2004)
Anneke K Raney, Robert K Hamatake, Zhi Hong, HEP DART 2003: Frontiers in drug development for viral hepatitis. Expert Opinion on Investigational Drugs. ,vol. 13, pp. 289- 293 ,(2004) , 10.1517/13543784.13.3.289
Maged A. Michael, Howard B. Cottam, Donald F. Smee, Roland K. Robins, Ganesh D. Kini, Alkylpurines as immunopotentiating agents. Synthesis and antiviral activity of certain alkylguanines. Journal of Medicinal Chemistry. ,vol. 36, pp. 3431- 3436 ,(1993) , 10.1021/JM00074A025